S&P 500, Nasdaq fall for 2nd day as tech slides on AI worries with Google earnings ahead
US stocks fell for a second day as investors weighed tech earnings and AI-related worries. The S&P 500 fell about 0.5% and the Nasdaq Composite over 1.5%. Alphabet shares dropped nearly 2% before results, with after-hours weakness tied to higher-than-expected capex. Nvidia, Amazon, Tesla and AMD also declined; ADP showed 22,000 private jobs added in January.
How this was made
The 30-second read
Why it matters
Alphabet’s after-hours reaction to higher capex, AMD’s weak sales outlook, and broader AI/tech rotation are the main equity catalysts. Separately, pharma guidance divergence (LLY up, NVO down) provides counter-sentiment within defensives.
Market read
Traders get a same-day catalyst mix: Alphabet capex repricing, AMD AI-demand skepticism, and pharma guidance divergence, all layered on a broader AI-driven tech risk-off tape.
What to watch
The article mixes multiple catalysts (jobs data delay, ADP miss, pharma guidance) that can distort pure AI read-through; traders should separate idiosyncratic guidance moves from sector correlation.
Background
The piece frames a second straight day of US equity weakness as investors weigh a fresh earnings wave and AI disruption fears, with Alphabet results and capex guidance as a focal point.
Ticker impact
Alphabet is cited as falling nearly 2% ahead of earnings, with after-hours volatility tied to higher-than-expected capex.
Choppy to downside-biased near-term as investors reprice AI spend intensity versus near-term monetization.
The article attributes a sharp after-hours drop to higher capex despite beating earnings and revenue, which typically pressures valuation multiples.
Alphabet (GOOGL) is described as tanking in after-hours after beating earnings and revenue but announcing bigger-than-expected capex.
Likely continued volatility and potential further downside if investors focus on the capex range versus expectations.
The text provides a specific capex range ($175B to $185B) versus a much lower Street model (~$120B), supporting a negative repricing.
Nvidia is reported down over 3% as tech slides on AI worries and software/tech selloff spillover.
Near-term downside pressure or underperformance versus broader market while AI-growth fears dominate.
The article links NVDA’s drop directly to AI worries and rotation away from tech, not to a new NVDA-specific fundamental disclosure.
Amazon is reported sliding over 2% during the tech selloff tied to AI worries and rotation into value.
Likely remains correlated with tech sentiment until a new AMZN-specific catalyst emerges.
The article does not cite an AMZN-specific news item, only price weakness within the sector move.
Tesla is reported down more than 3% as the broader tech-driven selloff weighs on markets.
Short-term bias lower if tech weakness persists; otherwise mean reversion possible.
The article attributes the move to market-wide rotation and AI worries, not TSLA fundamentals.
AMD shares are described as plummeting after a weak sales outlook raised doubts about competing with Nvidia in AI.
Further downside risk until investors gain clarity on the sales outlook and competitive positioning.
Unlike other names, the article explicitly ties AMD’s drop to its own weak sales outlook, which is actionable for positioning.
Apple is said to close up more than 2% after beating expectations, with record iPhone revenue and AI-enabled Siri focus.
Relative strength likely to persist near-term if investors keep rewarding execution and product-cycle visibility.
The article provides concrete AAPL datapoints (record iPhone revenue $85.3B, beat-driven outlook) and mentions AI-enabled Siri as an upcoming catalyst.
Eli Lilly is reported jumping after posting an upbeat 2026 profit forecast on weight-loss drug demand.
Upside bias while the market digests the 2026 profit forecast and demand durability.
The article cites a specific forward-looking forecast and a clear price reaction (jumping), which is typically decision-relevant.
Market effects
AI capex uncertainty and weak AI-related sales outlook are pressuring software and semis, reinforcing rotation away from high-multiple tech.
The article claims spillover selling hit Europe and Asia, implying global risk appetite is being tempered by AI disruption fears.
Higher-than-expected mega-cap AI spending expectations versus near-term monetization is a cross-market valuation driver.
Counterpoint
The Alphabet capex shock may be interpreted as necessary scale-up rather than demand weakness, so the selloff could be overdone if revenue growth remains strong.
Key entities
- companyAlphabet
Earnings beat paired with higher-than-expected 2026 capex range, driving after-hours volatility.
- companyAdvanced Micro Devices
Weak sales outlook cited as causing a sharp selloff tied to AI competition concerns.
- companyApple
Relative strength on record iPhone revenue and AI-enabled Siri expectations.
- companyEli Lilly
Upbeat 2026 profit forecast supports a sharp stock jump.
- companyNovo Nordisk
Steep sales decline forecast for Ozempic and Wegovy drives a selloff.
